Inhibitory and activators of cyclic nucleotide phosphodiesterase.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism*; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D002540:Cerebral Cortex / Q000201:enzymology; D002614:Chelating Agents / Q000494:pharmacology; D006152:Cyclic GMP / Q000378:metabolism*; D004789:Enzyme Activation / Q000187:drug effects; D006168:Guinea Pigs; D007093:Imidazoles / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D007700:Kinetics; D009712:Nucleotides, Cyclic / Q000494:pharmacology; D009928:Organ Specificity; D010208:Papaverine / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D011720:Pyrazoles / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D011799:Quinazolines / Q000494:pharmacology; D013045:Species Specificity; D013453:Sulfonylurea Compounds / Q000494:pharmacology; D014970:Xanthines / Q000494:pharmacology
D000929:Antidepressive Agents, Tricyclic; D002395:Catecholamines; D002614:Chelating Agents; D007093:Imidazoles; D007328:Insulin; D009712:Nucleotides, Cyclic; D011720:Pyrazoles; D011725:Pyridines; D011799:Quinazolines; D013453:Sulfonylurea Compounds; D014970:Xanthines; D010208:Papaverine; D010727:Phosphoric Diester Hydrolases; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D006152:Cyclic GMP